SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+33.62%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.69B
AUM Growth
+$1.69B
(-5.1%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-22.25%
Top 10 Holdings %
Top 10 Hldgs %
52.96%
Holding
89
New
27
Increased
18
Reduced
14
Closed
20
Top Buys
| 1 |
Novo Nordisk
NVO
|
$78.6M |
| 2 |
Incyte
INCY
|
$58.7M |
| 3 |
argenx
ARGX
|
$41.2M |
| 4 |
Idexx Laboratories
IDXX
|
$40.6M |
| 5 |
Insulet
PODD
|
$34.5M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$437M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$150M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$45.9M |
| 4 |
Eli Lilly
LLY
|
$37.6M |
| 5 |
Cytokinetics
CYTK
|
$34.6M |
Sector Composition
| 1 | Healthcare | 99.18% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Eli Lilly
LLY
$661B
| – | – |
-64,525
| Closed | -$37.6M |
|
77
MoonLake Immunotherapeutics
MLTX
$3.78B
| – | – |
-113,757
| Closed | -$6.87M |
|
78
Penumbra
PEN
$10.5B
| – | – |
-2,000
| Closed | -$503K |
|
79
Sanofi
SNY
$122B
| – | – |
-598,978
| Closed | -$29.8M |
|
80
Stryker
SYK
$149B
| – | – |
-62,788
| Closed | -$18.8M |
|
81
Vir Biotechnology
VIR
$765M
| – | – |
-4,495
| Closed | -$45.2K |
|
82
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
SPRB
83
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-22,767
| Closed | -$66.7K |
|
|
GRTX
84
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| – | – |
-3,083,712
| Closed | -$448K |
|
|
CBAY
85
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-1,411,769
| Closed | -$33.3M |
|
|
KRTX
86
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-1,381,149
| Closed | -$437M |
|
|
RYZB
87
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-2,419,528
| Closed | -$150M |
|
|
IMGN
88
DELISTED
Immunogen Inc
IMGN
| – | – |
-1,546,902
| Closed | -$45.9M |
|